A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
PHASE4CompletedINTERVENTIONAL
Enrollment
144
Participants
Timeline
Start Date
July 16, 2012
Primary Completion Date
May 2, 2017
Study Completion Date
August 21, 2017
Conditions
MCNSMinimal Change Nephrotic Syndrome (MCNS)
Interventions
DRUG
Tacrolimus
Oral
DRUG
Prednisolone
Oral
Trial Locations (1)
Unknown
Seoul
All Listed Sponsors
lead
Astellas Pharma Korea, Inc.
INDUSTRY
NCT01763580 - A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome | Biotech Hunter | Biotech Hunter